Delta tocotrienol as a supplement to FOLFOXIRI in first-line treatment of metastatic colorectal cancer. A randomized, double-blind, placebo-controlled phase II study.
Louise RaunkildeTorben Frøstrup HansenBirgitte Mayland HavelundCaroline Emilie B ThomsenSøren Rafael RafaelsenJan LindebjergLars Henrik JensenPublished in: Acta oncologica (Stockholm, Sweden) (2023)
-tocotrienol.